Exit
In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 75% on this post-survey, as well as complete the evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.

Question Title

* 1. HCPs: What are your credentials?

Question Title

* 2. What is your community of practice?

Question Title

* 3. 48 yo Female patient w/ COVID
Diagnosed w/ stage 1️, B-cell lymphoma 1 yr ago
Treated w/ R-CHOP X 4 cycles; radiation
Fully vaccinated 4 flu & COVID (mRNA + 2 boosters) 9 mo ago

What risk factors does the patient have for severe disease?

Question Title

* 4. What type of COVID-19 treatment is indicated for all high-risk immunocompromised patients? 

Question Title

* 5. Which antiviral is first-line for hospitalized patients with risk factors for disease progression?

EVALUATION FORM

Question Title

* 6. What is your specialty?

Question Title

* 7. Please rate how well the activity:

  Strongly agree Agree Neutral Disagree Strongly disagree
Met the learning objectives
Met your educational needs
Reinforced and/or improved your current skills
Gave you tools and strategies to apply in practive
Improved your ability to treat or manage your patients

Question Title

* 8. After having participated in this activity, how confident are you in your ability to:

  Very confident Somewhat confident Neutral  Not very confident Not confident at all
SELECT the appropriate treatment regimen depending on the COVID-19 disease stage according to the most recent guidelines
DESCRIBE the evidence for the use of different therapeutics at different COVID-19 disease stages

Question Title

* 9. Please indicate the extent to which you agree the following faculty demonstrated expertise in the content area:

  Strongly agree Agree Neutral Disagree Strongly disagree
Nida Qadir, MD
Charlie Wray, DO

Question Title

* 10. As a result of what I learned, I intend to make changes in my practice:

Question Title

* 11. What change(s) will you incorporate into your practice as a result of what you have learned in this activity?

Question Title

* 12. Did the activity address strategies for overcoming barriers to optimal patient care? (e.g. access to care, cost, etc…)

Question Title

* 13. Was the content presented evidence-based and clinically relevant?

Question Title

* 14. Was the material presented in an objective manner and free of commercial bias? (Commercial bias is defined as promoting a specific proprietary business interest of a commercial entity, and/or not including a balanced view of therapeutic options)

Question Title

* 15. How many years have you been in practice?

Question Title

* 16. What is the most important take-away for you from this activity?

Question Title

* 17. What topics related to COVID-19 would you like to learn more about in future educational activities?

Question Title

* 18. Is there anything else you would like to communicate to us about this activity?

Question Title

* 19. If you are claiming credit, please provide your contact information so we can send your certificate. Certificates will be provided within 4-6 weeks.

Please note that we will not forward or sell your contact information.

Question Title

* 20. I certify that I have participated in the continuing education activity entitled, “Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 Tweetorial #3: Approved Therapies" and claim 0.25 AMA PRA Category 1 CreditTM.

Thank you for participating in our activity and completing the necessary paperwork. Please allow 4-6 weeks to receive your certificate. For information about the certification of this program, please contact National Jewish Health at proed@njhealth.org.
( Privacy & Cookie Notice

T